Controlling the balance between osteoblastogenesis and adipogenesis and the consequent therapeutic implications

被引:346
作者
Nuttall, ME
Gimble, JM
机构
[1] Centocor Inc, Malvern, PA 19355 USA
[2] Louisiana State Univ, Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA
关键词
D O I
10.1016/j.coph.2004.03.002
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The increase in marrow adipogenesis associated with osteoporosis and age-related osteopenia is well known clinically. However, we are only now beginning to understand the mechanisms that control the differentiation of mesenchymal stem cells to either osteoblasts or adipocytes. Recent work with gene silencing and overexpression has provided insight into critical pathways that determine the fate of these multipotential cells. One of these pathways - that of the nuclear hormone receptor peroxisome proliferator activated receptor-gamma - when activated, promotes adipogenesis and inhibits osteogenesis. This in vitro mechanism of action has been confirmed in vivo using ligands to this receptor. Discovery of this and other targets and pathways, such as Writ signaling, notch/delta/jagged ligands and receptors, and RhoA gene expression, provides new insights into mesenchymal stem cell differentiation. These pathways provide exciting future pharmacological targets with which to enhance bone formation and therefore reduce the risk of fracture.
引用
收藏
页码:290 / 294
页数:5
相关论文
共 42 条
[1]   PPARγ insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors [J].
Akune, T ;
Ohba, S ;
Kamekura, S ;
Yamaguchi, M ;
Chung, UI ;
Kubota, N ;
Terauchi, Y ;
Harada, Y ;
Azuma, Y ;
Nakamura, K ;
Kadowaki, T ;
Kawaguchi, H .
JOURNAL OF CLINICAL INVESTIGATION, 2004, 113 (06) :846-855
[2]  
Aldred MA, 2000, HUM MUTAT, V16, P183, DOI 10.1002/1098-1004(200009)16:3<183::AID-HUMU1>3.0.CO
[3]  
2-L
[4]  
BERESFORD JN, 1992, J CELL SCI, V102, P341
[5]   High bone density due to a mutation in LDL-receptor-related protein 5 [J].
Boyden, LM ;
Mao, JH ;
Belsky, J ;
Mitzner, L ;
Farhi, A ;
Mitnick, MA ;
Wu, DQ ;
Insogna, K ;
Lifton, RP .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (20) :1513-1521
[6]   CHANGES IN TRABECULAR BONE, HEMATOPOIESIS AND BONE-MARROW VESSELS IN APLASTIC-ANEMIA, PRIMARY OSTEOPOROSIS, AND OLD-AGE - A COMPARATIVE HISTOMORPHOMETRIC STUDY [J].
BURKHARDT, R ;
KETTNER, G ;
BOHM, W ;
SCHMIDMEIER, M ;
SCHLAG, R ;
FRISCH, B ;
MALLMANN, B ;
EISENMENGER, W ;
GILG, T .
BONE, 1987, 8 (03) :157-164
[7]   PTHrP inhibits adipocyte differentiation by down-regulating PPARγ activity via a MAPK-dependent pathway [J].
Chan, GK ;
Deckelbaum, RA ;
Bolivar, I ;
Goltzman, D ;
Karaplis, AC .
ENDOCRINOLOGY, 2001, 142 (11) :4900-4909
[8]   Parathyroid hormone-related peptide interacts with bone morphogenetic protein 2 to increase osteoblastogenesis and decrease adipogenesis in pluripotent C3H10T1/2 mesenchymal cells [J].
Chan, GK ;
Miao, DS ;
Deckelbaum, R ;
Bolivar, I ;
Karaplis, A ;
Goltzman, D .
ENDOCRINOLOGY, 2003, 144 (12) :5511-5520
[9]   OSTEOBLASTIC GENE-EXPRESSION DURING ADIPOGENESIS IN HEMATOPOIETIC SUPPORTING MURINE BONE-MARROW STROMAL CELLS [J].
DORHEIM, MA ;
SULLIVAN, M ;
DANDAPANI, V ;
WU, XY ;
HUDSON, J ;
SEGARINI, PR ;
ROSEN, DM ;
AULTHOUSE, AL ;
GIMBLE, JM .
JOURNAL OF CELLULAR PHYSIOLOGY, 1993, 154 (02) :317-328
[10]   Deficiency of the α-subunit of the stimulatory G protein and severe extraskeletal ossification [J].
Eddy, MC ;
De Beur, SMJ ;
Yandow, SM ;
McAlister, WH ;
Shore, EM ;
Kaplan, FS ;
Whyte, MP ;
Levine, MA .
JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 (11) :2074-2083